Trials / Completed
CompletedNCT04278573
Intralesional Vitamin D Injection for Treatment of Common Warts
Efficacy of Intralesional Vitamin D Injection for Treatment of Common Warts: A Randomized Controlled Trial
- Status
- Completed
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 77 (actual)
- Sponsor
- Stephen P. Merry · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
Researchers are trying to find out if injecting Vitamin D into a wart is an effective treatment.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Vitamin D3 | Intralesional injection of 0.3 ml 40,000 IU/ml vitamin D3 into one wart |
| DRUG | Placebo | 0.3 ml injection of sterilized sesame oil with no active study ingredient |
Timeline
- Start date
- 2020-10-20
- Primary completion
- 2023-04-04
- Completion
- 2023-04-04
- First posted
- 2020-02-20
- Last updated
- 2024-04-30
- Results posted
- 2024-04-30
Locations
1 site across 1 country: United States
Regulatory
- FDA-regulated drug study
Source: ClinicalTrials.gov record NCT04278573. Inclusion in this directory is not an endorsement.